195
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Long Duration of Reflux Symptoms is the Predominant Risk Factor for Depression in Vietnamese Patients with Gastroesophageal Reflux Disease

ORCID Icon &
Pages 2141-2150 | Received 11 Jul 2022, Accepted 05 Sep 2022, Published online: 23 Sep 2022

References

  • Dirac MA, Safiri S, Tsoi D, et al. The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepato. 2020;5(6):561–581. doi:10.1016/S2468-1253(19)30408-X
  • Chou P-H, Lin C-C, Lin C-H, et al. Prevalence of gastroesophageal reflux disease in major depressive disorder: a population-based study. Psychosomatics. 2014;55(2):155–162. doi:10.1016/j.psym.2013.06.003
  • Kim SY, Kim H-J, Lim H, Kong IG, Kim M, Choi HG. Bidirectional association between gastroesophageal reflux disease and depression: two different nested case-control studies using a national sample cohort. Sci Rep. 2018;8(1):1–8.
  • Choi JM, Yang JI, Kang SJ, et al. Association between anxiety and depression and gastroesophageal reflux disease: results from a large cross-sectional study. J Neurogastroenterol Motil. 2018;24(4):593–602. doi:10.5056/jnm18069
  • Yang X-J. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J Gastroenterol. 2015;21(14):4302.
  • Bilgi MM, Vardar R, Yıldırım E, Veznedaroğlu B, Bor S. Prevalence of psychiatric comorbidity in symptomatic gastroesophageal reflux subgroups. Dig Dis Sci. 2016;62(4):984–993. doi:10.1007/s10620-016-4273-4
  • Oh J-H, Kim T-S, Choi M-G, et al. Relationship between psychological factors and quality of life in subtypes of gastroesophageal reflux disease. Gut Liver. 2009;3(4):259–265. doi:10.5009/gnl.2009.3.4.259
  • Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis. 2004;22(2):108–114. doi:10.1159/000080308
  • Matsuhashi N, Kudo M, Yoshida N, et al. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study. J Gastroenterol. 2015;50(12):1173–1183. doi:10.1007/s00535-015-1073-0
  • Kamolz T, Granderath FA, Pointner R. Does major depression in patients with gastroesophageal reflux disease affect the outcome of laparoscopic antireflux surgery? Surg Endosc. 2003;17(1):55–60. doi:10.1007/s00464-002-8504-8
  • Goh KL. Reasons for the rise of gastroesophageal reflux disease in Asia. In: The Rise of Acid Reflux in Asia. New Delhi: Springer; 2018:27–36.
  • Quach DT, Pham QTT, Tran TLT, et al. Clinical characteristics and risk factors of gastroesophageal reflux disease in Vietnamese patients with upper gastrointestinal symptoms undergoing esophagogastroduodenoscopy. JGH Open. 2021;5(5):580–584. doi:10.1002/jgh3.12536
  • World Health Organization. Depression and other common mental disorders: global health estimates; 2017. Available from: https://appswhoint/iris/handle/10665/254610. Accessed September 15, 2022.
  • Chen Y-H, Wang H. The association between depression and gastroesophageal reflux based on phylogenetic analysis of miRNA biomarkers. Curr Med Chem. 2020;27(38):6536–6547. doi:10.2174/0929867327666200425214906
  • World Health Organization. Mental health in Vietnam; 2014. Available from: https://wwwwhoint/vietnam/health-topics/mental-health. Accessed September 15, 2022.
  • Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30(10):1030–1038. doi:10.1111/j.1365-2036.2009.04142.x
  • Beck AT, Steer RA. Beck Depression Inventory Manual. San Antonio, TX: Psychological Corporation; 1993.
  • Beck AT, Beamesderfer A. Assessment of Depression: the depression inventory. In: Psychological Measurements in Psychopharmacology. S. Karger; 1974:151–169.
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
  • Wong MW, Bair MJ, Chang WC, et al. Clinical and psychological characteristics in gastroesophageal reflux disease patients overlapping with laryngopharyngeal reflux symptoms. J Gastroenterol Hepatol. 2019;34(10):1720–1726. doi:10.1111/jgh.14651
  • Moraes-Filho JPP, Navarro-Rodriguez T, Eisig JN, Barbuti RC, Chinzon D, Quigley EMM. Comorbidities are frequent in patients with gastroesophageal reflux disease in a tertiary health care hospital. Clinics. 2009;64(8):785–790. doi:10.1590/S1807-59322009000800013
  • Nakov R, Dimitrova‐Yurukova D, Snegarova V, Nakov V, Fox M, Heinrich H. Increased prevalence of gastrointestinal symptoms and disorders of gut‐brain interaction during the COVID‐19 pandemic: an internet‐based survey. Neurogastroenterol Motil. 2021;34(2):e14197.
  • Hungin APS, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther. 2009;30(4):331–342. doi:10.1111/j.1365-2036.2009.04047.x
  • Zhou J, Dou W, Wei Y, et al. Anxiety and depression prevalence in Chinese patients with gastroesophageal reflux disease: a Meta-analysis. Chin Gen Pract. 2021;24(5):608–613.
  • Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of beck depression inventories-IA and-II in psychiatric outpatients. J Pers Assess. 1996;67(3):588–597. doi:10.1207/s15327752jpa6703_13
  • Salk RH, Hyde JS, Abramson LY. Gender differences in depression in representative national samples: meta-analyses of diagnoses and symptoms. Psychol Bull. 2017;143(8):783–822. doi:10.1037/bul0000102
  • You Z-H, Perng C-L, Hu L-Y, et al. Risk of psychiatric disorders following gastroesophageal reflux disease: a nationwide population-based cohort study. Eur J Intern Med. 2015;26(7):534–539. doi:10.1016/j.ejim.2015.05.005
  • Li Z, Li Y, Chen L, Chen P, Hu Y. Prevalence of depression in patients with hypertension. Medicine. 2015;94(31):1.
  • Palmer S, Vecchio M, Craig JC, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84(1):179–191. doi:10.1038/ki.2013.77
  • Mukhtar K, Nawaz H, Abid S. Functional gastrointestinal disorders and gut-brain axis: what does the future hold? World J Gastroenterol. 2019;25(5):552–566. doi:10.3748/wjg.v25.i5.552
  • Liang S, Wu X, Hu X, Wang T, Jin F. Recognizing depression from the microbiota–gut–brain axis. Int J Mol Sci. 2018;19(6):1592. doi:10.3390/ijms19061592
  • Macke L, Schulz C, Koletzko L, Malfertheiner P. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies. Aliment Pharmacol Ther. 2020;51(5):505–526. doi:10.1111/apt.15604